Radiomics: the bridge between medical imaging and personalized medicine
- 4 October 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Clinical Oncology
- Vol. 14 (12), 749-762
- https://doi.org/10.1038/nrclinonc.2017.141
Abstract
Radiomics, the high-throughput mining of quantitative image features from standard-of-care medical imaging that enables data to be extracted and applied within clinical-decision support systems to improve diagnostic, prognostic, and predictive accuracy, is gaining importance in cancer research. Radiomic analysis exploits sophisticated image analysis tools and the rapid development and validation of medical imaging data that uses image-based signatures for precision diagnosis and treatment, providing a powerful tool in modern medicine. Herein, we describe the process of radiomics, its pitfalls, challenges, opportunities, and its capacity to improve clinical decision making, emphasizing the utility for patients with cancer. Currently, the field of radiomics lacks standardized evaluation of both the scientific integrity and the clinical relevance of the numerous published radiomics investigations resulting from the rapid growth of this area. Rigorous evaluation criteria and reporting guidelines need to be established in order for radiomics to mature as a discipline. Herein, we provide guidance for investigations to meet this urgent need in the field of radiomics.Keywords
This publication has 116 references indexed in Scilit:
- Predicting outcomes in radiation oncology—multifactorial decision support systemsNature Reviews Clinical Oncology, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Reproducible Research in Computational ScienceScience, 2011
- Predictive, personalized, preventive, participatory (P4) cancer medicineNature Reviews Clinical Oncology, 2011
- The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancerRadiotherapy and Oncology, 2010
- Improving Normal Tissue Complication Probability Models: The Need to Adopt a “Data-Pooling” CultureInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectivesThe Lancet Oncology, 2008
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences of the United States of America, 2008
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004